Expression, function and clinical relevance of MIA (melanoma inhibitory activity)

Histology and Histopathology

Volumn 17, Issue 1, 2002, Pages 289-300

  Bosserhoff, Anja Katrin ^a   Buettner, R ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Invasion; Malignant melanoma; Metastasis; Serum marker; Transcriptional regulation

Indexed keywords

EPITOPE; FIBROCYTE DERIVED PROTEIN; MELANOMA INHIBITORY ACTIVITY LIKE PROTEIN; MELANOMA INHIBITORY ACTIVITY PROTEIN; MELANOMA INHIBITORY ACTIVITY PROTEIN 2; MESSENGER RNA; OTORAPLIN; PROTEIN; TANGO PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADENOCARCINOMA; AUTOCRINE EFFECT; BREAST CANCER; CANCER GROWTH; CANCER INVASION; CARTILAGE CELL; CARTILAGE DEGENERATION; CELL SECRETION; CELL SURFACE; CHONDROSARCOMA; CLONING; COLON CANCER; DISEASE MARKER; DISEASE SEVERITY; EXTRACELLULAR MATRIX; FOLLOW UP; GROWTH REGULATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LABORATORY; MELANOMA; MELANOMA CELL; METASTASIS; MULTIGENE FAMILY; NONHUMAN; NUCLEOTIDE SEQUENCE; PATIENT MONITORING; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; PROTEIN VARIANT; REGULATORY MECHANISM; REVIEW; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION;

AMINO ACID SEQUENCE; ANIMALS; BIOLOGICAL MARKERS; CHONDROCYTES; CLONING, MOLECULAR; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOMA; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PROTEIN CONFORMATION; TRANSCRIPTION, GENETIC;

EID: 0036159908     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Cloning of a novel malignant melanoma-derived growth regulatory protein, MIA
2. Autocrine tumour cell growth inhibiting activities from human malignant melanoma
3. Structure and promoter analysis of the gene encoding the human melanoma-inhibiting-protein, MIA
4. The mouse MIA/CD-RAP gene: Structure, chromosomal localization and expression in cartilage and chondrosarcoma
5. Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma
6. MIA (melanoma inhibitory activity): Biologische Funktionen und klinische Relevanz beim malignen Melanom
7. In situ expression patterns of melanoma-inhibiting activity (MIA) in malignant melanomas and breast cancers
8. Elevated MIA serum levels are of relevance for management of metastasized malignant melanomas: Results of a German multicenter study
9. Functional role of MIA in regulating metastasis of malignant melanoma cells in an vivo model
10. Fdp, a new fibrocyte-derived protein related to MIA/CD-RAP, has an in vitro effect on the early differentiation of the inner ear mesenchyme
11. S100-Beta, melanoma-inhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American Joint Committee on Cancer stage IV melanoma
12. Cloning of a retinoic acid-sensitive mRNA expressed in cartilage and during chondrogenesis
13. Comparison of S100 protein and MIA protein as serum marker for malignant melanoma
14. Melanoma-inhibitory activity protein, a useful marker to monitor melanoma patients treated with immunotherapy
15. Characterisation of a transcription factor binding site, specifically activating MIA transcription in malignant melanoma
16. Overexpression of melanoma inhibitory activity (MIA) enhances extravasation and metastasis of A-mel 3 melanoma cells in vivo
17. Comparison of two prognostic markers for malignant melanoma: MIA and S100 beta
18. Assignment of the human melanoma inhibitory activity gene (MIA) to 19q13.4 by fluorescence in situ hybridization (FISH)
19. Structure of melanoma inhibitory activity protein, a member of a recently identified family of secreted proteins
20. Mia (melanoma inhibitory activity): A potential serum marker for rheumatoid arthritis
21. Expression of melanoma inhibitory activity (MIA) in melanoma and non-melanoma tissue specimens
22. Identification and characterization of an inner ear-expressed human melanoma inhibitory activity (MIA)-like gene (MIAL) with a frequent polymorphism that abolishes translation
23. A novel conserved cochlear gene, OTOR: Identification, expression analysis, and chromosomal mapping
24. Cartilage-derived retinoic acid-sensitive protein and type II collagen expression during fracture healing are potential targets for Sox9 regulation
25. Melanoma inhibitory activity (MIA). Evaluation of a new tumor-associated antigen as a serum marker for uveal melanomas
26. Comparative study on the clinical use of protein S-100B and MIA (melanoma inhibitory activity) in melanoma patients
27. MIA as a reliable tumor marker in the serum of patients with malignant melanoma
28. 15N assignment of the human melanoma inhibitory activity (MIA) protein
29. The extracellular human melanoma inhibitory activity (MIA) protein adopts an SH3 domain-like fold
30. Identification of malanoma inhibitory activity and other differentially expressed messenger RNAs in human melanoma cell lines with different metastatic capacity by messenger RNA differential display
31. Seropositivity for MIA and S100 in patients with gastrointestinal carcinomas
32. Regulation of the mouse cartilage-derived retinoid acid-sensitive protein gene by the transcription factor AP-2
33. The 2.2-kb promoter of cartilage-derived retinoic acid-sensitive protein controls gene expression in cartilage and embryonic mammary buds of transgenic mice
34. Trans-activation of the mouse cartilage-derived retinoic acid-sensitive protein gene by Sox9